BPC-157

BPC-157 is a pentadecapeptide derived from gastric juice that people run mainly for injury recovery and tissue repair, gut and digestive healing, and joint and ligament support, with community reports skewing positive across all three. Most people dose around 500 µg daily, with reported use spanning 50 µg to 10 mg; the one clinician protocol on record runs a much lower 10 µg twice daily by subcutaneous injection. There's no FDA-approved indication, so all human use is off-label or compounded, and the off-label evidence base is thinner than the online discourse suggests. Nausea or other GI upset occasionally surfaces in community reports.

Half-life~4 h

Data last updated

ClinicalResearchDepthClinicalResearchEfficacyClinicalResearchSideEffectsno dataAnecdotalEfficacyAnecdotalSideEffectsPrice1.91.73.92.54.0

Measured on 5 of 6 axes

Research Evidence

Evidence shape

BPC-157 currently holds a low evidence tier, as human data is restricted to a handful of exploratory studies focused on mechanistic insights and isolated treatment reports. While the peptide appears in four distinct research areas, including hamstring muscle strain and diagnostic investigations, there are no completed clinical trials to validate these findings. The current research landscape remains thin, characterized by a single active registered trial and a reliance on preclinical models, leaving the clinical efficacy of the peptide unverified at scale.

Depthhow much
1 registered trial
1 recruiting / active
Breadthhow many areas
4 indications mapped
3 thin / exploratory · 1 animal-only · 2 single-trial long-tail
Qualityhow rigorous
No completed trials
Breadth and depth18 rows captured
Human
direct clinical signal
4
Animal
translational support
12
In vitro
mechanistic support
2
HighMediumLow

Anecdotal efficacy

BPC-157 side effects

Clinical research side effects

Clinical safety table not projected yet.

Anecdotal side effects

Price

Full buying guide →
1
Choicepeps
--
1000 mg
$249.99
$0.25/mg
2
BOC Peptide
--
200 mg
$80.00
$0.4/mg
3
Lilipeptide
China
50 mg×10
$52.00
$1.04/mg
4
Mrbeetoe
--
50 mg
$60.00
$1.2/mg
5
Nexaph
USA
100 mg×10
$134.00
$1.34/mg
6
Sculpt Peptide
GB
25 mg
$33.56
$1.34/mg

price offers can be sorted by column

1-6 of 372

BPC-157 dosing & protocol

How BPC-157 is dosed across research, clinician, and community sources — each evidence tier kept separate so the dose range, frequency, timing, and cycling stay visible without flattening different levels of evidence.

Research trials
Published clinical-trial protocols · n = 1
Typical dose
10 mg
typical
0
2 mg
4 mg
6 mg
8 mg
10 mg
across 1 dosed source · darker = more agree
Frequency
single dose
Route
subQ

In the research trial for BPC‑157, the single source reported a subcutaneous 10 mg dose given once, with no repeat dosing or cycling described.

1 source
Clinician practice
Doctor & published-protocol guidance · n = 1
Typical dose
10 µg
typical
0
2 mg
4 mg
6 mg
8 mg
10 mg
across 1 dosed source · darker = more agree
By reported cadence
Twice daily10 µg · n=1
Frequency
twice daily
Route
subQ

A single clinician source reports 10 mcg subcutaneously twice daily, with no cycle duration or additional timing detail included.

1 source
Anecdotal
Community-reported real-world use · n = 33
Typical dose
500 µg50 µg – 10 mg
typical
0
2 mg
4 mg
6 mg
8 mg
10 mg
distribution of 37 reported doses · darker = more
By reported cadence· tap a row to filter the chart
Frequency
mostly daily
Route
subQ

Most of the 33 community reports don't specify how often they dose; among those who do, daily is the dominant cadence at around 1 mg subQ. A small minority dose twice daily at 250 mcg per injection.

33 sources

Related peptides

TB-500Pentosan PolysulfateB7-33KPVKLOWWolverineARA-290